2022
DOI: 10.1016/j.carrev.2022.02.020
|View full text |Cite
|
Sign up to set email alerts
|

Rotational Atherectomy in Acute Coronary Syndrome: A Meta-Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 36 publications
0
4
0
1
Order By: Relevance
“…Several studies have con rmed that RA is feasible in ACS patients, with comparable procedural complications and short-term MACE [12][13][14][15] . Our study demonstrated a similar cardiac death rate of about 2.5% following RA in ACS patients.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Several studies have con rmed that RA is feasible in ACS patients, with comparable procedural complications and short-term MACE [12][13][14][15] . Our study demonstrated a similar cardiac death rate of about 2.5% following RA in ACS patients.…”
Section: Discussionmentioning
confidence: 99%
“…However, the use of RA in patients with ACS remains controversial, considering the plaques are often unstable and even thrombotic, while thrombus-rich lesions are currently considered one of the contraindications for RA [9][10][11] . Despite some existing studies suggesting that RA PCI is technically feasible and safe in ACS patients with comparable procedural complications and short-term major adverse cardiac events (MACE) [12][13][14][15] , few studies focused on RA in ACS patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…To tackle these highly demanding lesions, several debulking modalities (such as rotational, orbital, and laser atherectomy, or the recently introduced shockwave intravascular lithotripsy) have become a part of contemporary clinical practice. Despite the well-established safety and efficiency of the atherectomy devices, utilization in the ACS subset is burdened with worse outcomes compared to stable patients [ 26 , 27 ]. Due to the novelty of the shockwave device, the evidence supporting the use of S-IVL in the ACS subset comes mainly from case reports, studies or low-number registries, which is encouraging [ 28 , 29 , 30 , 31 , 32 ].…”
Section: Discussionmentioning
confidence: 99%
“…10 Trong một phân tích gộp hồi cứu 1237 bệnh nhân ACS cũng cho kết quả tương tự, kết luận được đưa ra là RA khả thi cho bệnh nhân ASC khi so sánh với nhóm RA thường quy trong ngắn hạn nhưng có xu hướng làm tăng MACE trong dài hạn. 11…”
Section: đặC đIểm Về Chẩn đOán Bệnhunclassified